Citation: J. Mauskopf et al., THE COST-EFFECTIVENESS OF TREATMENT WITH LAMIVUDINE AND ZIDOVUDINE COMPARED WITH ZIDOVUDINE ALONE - A COMPARISON OF MARKOV MODEL AND TRIAL DATA ESTIMATES, American journal of managed care, 4(7), 1998, pp. 1004-1012
Citation: J. Mauskopf et al., A STRATEGY FOR COLLECTING PHARMACOECONOMIC DATA DURING PHASE II III CLINICAL-TRIALS/, PharmacoEconomics, 9(3), 1996, pp. 264-277
Authors:
DOYLE JJ
CASCIANO JP
ARIKIAN SR
MAUSKOPF J
PAUL JE
Citation: Jj. Doyle et al., FULL-COST DETERMINATION OF DIFFERENT LEVELS OF CARE IN THE INTENSIVE-CARE UNIT - AN ACTIVITY-BASED COSTING APPROACH, PharmacoEconomics, 10(4), 1996, pp. 395-408
Authors:
SCHULMAN KA
BUXTON M
GLICK H
SCULPHER M
GUZMAN G
KONG J
BACKHOUSE M
MAUSKOPF J
BELL L
EISENBERG JM
CALIFF RM
MCKENNA WJ
HARRELL FE
URETSKY BF
ADAMS KF
SWEDBERG KB
GHEORGHIADE M
ZANNAD F
HANDBERG E
DARIUS H
SOLERSOLER J
WHEELER WS
ARMSTRONG PW
PATTERSON H
MURALI S
BUTMAN S
KIRLIN PC
MILLER LW
JAFRI S
RICH S
COSTANZONORDIN MR
MCGOON M
HOSENPUD JD
RATKOVEC R
BRUNDAGE B
PRITZKER M
BOURGE R
REEVES W
FORGOSH L
VENTURA H
YOUNG JB
MANCINI D
MILLS RM
LIMACHER MC
LEE F
REVKIN J
KALBFLEISCH JM
FISHBEIN D
PRESSLER M
HAEUSSLEIN E
KARLSBERG RP
OCONNELL J
LEJEMTEL TH
THOMAS HM
SMITH WB
MCIVOR M
CINTRON GB
HAGER WD
MESSINEO FC
DOUGHERTY JE
HASSAPOYANNES C
HOOD W
MCGREW F
SANFORD CF
OCONNER CM
HOBBS RE
YARDLEY D
KAY R
MINOTTI J
EASTBURN TE
LINDENFELD J
LITMAN G
WICKEMEYER W
HORTON S
GILBERT EM
EICHORN E
RIBNER HS
CORDER C
PHILBIN E
NOCERO M
ELKAYAM U
JESSUP M
CRAWFORD M
CARSON P
REDDY HK
KLAPHOLZ M
HEYWOOD JT
SALINGER M
KARLSBERG R
BUSH D
HUNTER C
WOHNS D
EISENBERG P
WINSTON S
BUTCHER C
MASSIN E
WYNNE J
TONKON M
SPACCAVENTO L
DIVER D
GHALI J
HUTCHINS S
ANAND I
BEANLANDS D
KOSTUK W
PFLUGFELDER P
LANGLEBEN D
LATOUR P
MIZGALA H
RICCI D
MANYARI D
DARGIE HJ
DAVIDSON C
SWANTON H
HUBNER PJB
OAKLEY D
BROOKS N
JENNINGS K
GREENBAUM RA
PENNY WJ
NICHOLLS P
WALSH M
SUGRUE D
FENNELL W
HORGAN JH
JONDEAU G
CASTAIGNE A
LEMAREC H
WALGER P
PARK JW
DEBERRAZUETA JR
MOL MG
SANCHEZ MAG
CAPONNETTO S
MAGNANI B
GALIE N
DEVITA C
MASERI A
BAGGER JP
REMES J
WALDENSTROM A
SCHAUFELBERGER M
DIENSTI F
SIMOONS ML
KLEIN W
PACHER R
KEOGH A
HARLEY A
Citation: Ka. Schulman et al., RESULTS OF THE ECONOMIC-EVALUATION OF THE FIRST STUDY - A MULTINATIONAL PROSPECTIVE ECONOMIC-EVALUATION, International journal of technology assessment in health care, 12(4), 1996, pp. 698-713
Authors:
MAUSKOPF J
MARKOWITZ M
HALPERN MT
MURRAY M
Citation: J. Mauskopf et al., COST-EFFECTIVENESS MODEL FOR ESTIMATING THE VALUE OF LAMOTRIGINE (LAMICTAL) - A NEW DRUG FOR EPILEPSY TREATMENT, Neurology, 46(2), 1996, pp. 4132-4132
Citation: J. Mauskopf et al., THE NOTTINGHAM HEALTH PROFILE AS A MEASURE OF QUALITY-OF-LIFE IN ZOSTER PATIENTS - CONVERGENT AND DISCRIMINANT VALIDITY, Quality of life research, 3(6), 1994, pp. 431-435
Citation: R. Berzon et al., QUALITY-OF-LIFE MEASUREMENT FOR DECISIONS ABOUT THE USE OF NEW THERAPEUTIC DRUGS - A TALE OF 2 NEEDS, Quality of life research, 3(1), 1994, pp. 46-46
Authors:
MAUSKOPF J
TURNER BJ
MARKSON LE
HOUCHENS RL
FANNING TR
MCKEE L
Citation: J. Mauskopf et al., PATTERNS OF AMBULATORY CARE FOR AIDS PATIENTS, AND ASSOCIATION WITH EMERGENCY ROOM USE, Health services research, 29(4), 1994, pp. 489-510